These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Possible mechanisms of pathogenetic relations between disorders of carbohydrate and lipid metabolism in the development of atherosclerosis and type 2 diabetes mellitus]. Davidenkova EF; Liberman IS Vestn Akad Med Nauk SSSR; 1990; (12):3-7. PubMed ID: 2291324 [No Abstract] [Full Text] [Related]
4. [Abdominal obesity. The metabolic syndrome, arteriosclerosis and mortality]. Wirth A; Krone W Dtsch Med Wochenschr; 1993 Apr; 118(16):595-601. PubMed ID: 8482234 [No Abstract] [Full Text] [Related]
5. [Paraclinical and clinical correlations on the implications of obesity in the pathogenesis of diabetes mellitus and atherosclerosis]. Creţeanu G; Jalobceastâi D; Cepoi V; Beşchea M; Ursuleanu G; Stanciu R; Pleşcan C; Creţeanu M; Creţeanu G; Munteanu G Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):307-12. PubMed ID: 4089333 [No Abstract] [Full Text] [Related]
6. [Pathogenesis of atherosclerosis in diabetes mellitus. The role of insulin resistance and hyperinsulinemia]. Kostiuk Ep; Zubkova ST Fiziol Zh (1978); 1993; 39(5-6):93-8. PubMed ID: 8045324 [TBL] [Abstract][Full Text] [Related]
10. [Abnormalities of lipid metabolism in diabetes mellitus]. Murase T Nihon Rinsho; 1990 Dec; 48 Suppl():652-8. PubMed ID: 2086946 [No Abstract] [Full Text] [Related]
11. New concepts in the relationship obesity--non-insulin dependent diabetes mellitus. Björntorp P Eur J Med; 1992 Apr; 1(1):37-42. PubMed ID: 1341975 [No Abstract] [Full Text] [Related]
12. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism]. Andrééva-Gatéva P Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Qatanani M; Lazar MA Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046 [TBL] [Abstract][Full Text] [Related]
14. [Weight of obesity in (pre)type 2 diabetes in children and adolescents: how and when to screen for?]. Mouraux T; Dorchy H Arch Pediatr; 2005 Dec; 12(12):1779-84. PubMed ID: 16289780 [TBL] [Abstract][Full Text] [Related]
15. Advocacy is needed to promote research into diseases of physical inactivity. Booth F; Gordon S Exerc Sport Sci Rev; 2000 Oct; 28(4):145-7. PubMed ID: 11064846 [No Abstract] [Full Text] [Related]
16. Insulin resistance: from benign to type 2 diabetes mellitus. Goldstein BJ Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698 [TBL] [Abstract][Full Text] [Related]
17. [Type 2 diabetes--etiopathogenetic aspects]. Häntzschel U; Dempe A Z Gesamte Inn Med; 1985 Nov; 40(21):613-8. PubMed ID: 3911610 [TBL] [Abstract][Full Text] [Related]
18. [Insulin resistance and diabetes type 2 in overweight children]. Renders CM; Delemarre-van de Waal HA; Dekker JM; Hirasing RA Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2060-3. PubMed ID: 14606353 [TBL] [Abstract][Full Text] [Related]
19. The clinical implications of insulin resistance. Peters AL Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420 [TBL] [Abstract][Full Text] [Related]
20. [Modern concepts of the etiology and pathogenesis of type II diabetes mellitus]. Pfeiffer EF Internist (Berl); 1987 Apr; 28(4):218-27. PubMed ID: 3298121 [No Abstract] [Full Text] [Related] [Next] [New Search]